In its statement to USA TODAY, the FDA maintained that, in all post-approvals for food additives, our scientists continue to review relevant new information to determine whether there are safety questions and whether the use of such substance is no longer safe under the Federal Food, Drug, and Cosmetic Act.

Irradiation panel

Fig. 9. Selected images of damaged skin treated with P25TiO₂NPs 10% (left) and healthy skin treated with VitaminB2@P25TiO₂NPs 10% (right).

Inventory: Low inventory of mainstream producers, it is expected that the overall size of spot inventory today is low, and there is less stock in mainstream factories.2. Mentality: the buyer has to prepare goods in advance, and the new order price is slightly less willing to purchase in bulk; Because the seller's inventory is small, the manufacturer has no willingness to reduce the price of sales, and the demand for new orders in the market is relatively large.Trend: The load of titanium dioxide enterprises is stable, the willingness to ship at low prices is not strong, and the downstream buyers still have inventory digestion, and the intention to supplement orders in the short term is limited. It is expected that the market price of titanium dioxide is stable today, and the market trading atmosphere is more general.
According to the feedback of manufacturers, the new orders of mainstream factories maintain stable prices, and the overall new volume of the market is limited. On the demand side, the terminal basically had batch replenishment last month, and the purchase intention of new orders was low; On the supply side, mainstream manufacturers normally produce and deliver goods, and the actual output of the industry is stable. Most factories quote a new price of 17,000 yuan/ton or more market negotiation range reference 16000-17200 yuan/ton, plastics and papermaking related downstream feedback part of the tight model price is higher. Recent titanium dioxide raw materials are expected to weaken, titanium dioxide price support is relatively limited, comprehensive market factors, the current titanium dioxide market many buyers hold a wait-and-see mentality.

Challenges and Innovations

The color of barium sulphate, predominantly white, plays a crucial role in its identification and application across various industries. With the demand for high-quality barium sulphate soaring, choosing the right supplier becomes vital. Businesses must consider factors like purity, particle size, regulatory compliance, and customer service when sourcing barium sulphate to ensure they receive a product that meets their stringent requirements. As industries continue to evolve, reliable suppliers will remain indispensable in providing the necessary materials to support innovations and advancements.

Neutral

Europe

① Coatings: The downstream demand structure of domestic and overseas titanium dioxide is similar. Coatings are the largest application fields, accounting for 61% of the consumption. Among the four components of paint products, namely resin, pigments and fillers, solvents and additives, titanium dioxide accounts for 10% to 25% of the total cost, accounting for more than 90% of the total amount of pigments and fillers, and more than 95% of the total amount of white pigments.

For a mini-review published in the journal Particle and Fibre Technology in 2021, scientists wanted to evaluate whether Ti02 particles contributed to the development and/or exacerbation of irritable bowel disease, and whether they altered the four elements of intestinal barrier function: the intestinal microbiota, the immune system, the mucus layer, and the epithelium. The breakdown of these four elements can contribute to autoimmune, neurological, inflammatory, infectious, and metabolic diseases. Following their review, the researchers concluded: “Data indicate that TiO2 is able to alter the four compartments of IBF and to induce a low-grade intestinal inflammation associated or not with pre-neoplastic lesions.” 

On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):

“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
 
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
 
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”